Home Drugs SGLT2 inhibitors (drug class)
Registry trials: SGLT2 inhibitors (drug class) 24 registry trials linked to SGLT2 inhibitors (drug class) with registry status recruiting, of 94, newest start first. Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Each filter is a page of its own, so they work one at a time. Choose Whole list to start again.
Phase 4 Recruiting Started 2026-06-25 110 planned NCT07351643
Phase 3 Recruiting Started 2026-05-29 410 planned NCT06955260
Phase 4 Recruiting Started 2026-04-23 200 planned NCT07405216
Phase 2 Recruiting Started 2026-03-05 130 planned NCT07273838
Phase 4 Recruiting Started 2026-01-01 144 planned NCT07614230
Phase 3 Recruiting Started 2025-12-02 600 planned NCT07025629
Phase 4 Recruiting Started 2025-09-01 100 planned NCT07292909
Phase 3 Recruiting Started 2025-06-03 1,600 planned NCT07187570
Phase 4 Recruiting Started 2025-05-12 106 planned NCT06668389
Phase 4 Recruiting Started 2025-03-02 200 planned NCT06785116
Phase 2/3 Recruiting Started 2025-03-01 200 planned NCT06030843
Phase 2 Recruiting Started 2025-02-01 100 planned NCT07245069
Phase 3 Recruiting Started 2024-12-16 164 planned NCT05879276
Phase 4 Recruiting Started 2024-10-10 17,200 planned NCT06642272
Phase 3 Recruiting Started 2024-04-15 188 planned NCT06304857
Phase 4 Recruiting Started 2024-04-05 264 planned NCT06013865
Phase 3 Recruiting Started 2024-04-04 800 planned NCT05852704
Phase 4 Recruiting Started 2024-03-05 150 planned NCT06249945
Phase 4 Recruiting Started 2024-02-01 200 planned NCT07776054
Phase 4 Recruiting Started 2024-01-19 120 planned NCT06055452
Phase 2 Recruiting Started 2023-01-04 150 planned NCT06155604
Phase 2 Recruiting Started 2022-06-08 222 planned NCT05359263
Phase 4 Recruiting Started 2021-07-05 200 planned NCT04899479
Phase 4 Recruiting Started 2021-04-01 2,000 planned NCT05164263